Literature DB >> 31493431

Synthetic cathinone self-administration in female rats modulates neurotransmitter levels in addiction-related brain regions.

Julie A Marusich1, Elaine A Gay2, Scott L Watson2, Bruce E Blough2.   

Abstract

Synthetic cathinones are used for their stimulant-like properties. Stimulant-induced neurochemical changes are thought to occur at different times in different brain regions and neurotransmitter systems. This study sought to examine the behavioral and neurochemical effects of α-pyrrolidinopentiophenone (α-PVP) and mephedrone (4MMC) in female rats. Methods probed the chronology of effects of synthetic cathinone exposure. Female rats were trained to self-administer α-PVP, 4MMC, or saline. Drug exposure ceased after 7 days of autoshaping for half of each drug group; the other half self-administered for another 21 days. Amygdala, hippocampus, hypothalamus, PFC, striatum, and thalamus were extracted, and tissue was analyzed with electrochemical detection and liquid chromatography mass spectrometry. Responding was minimal during autoshaping; thus, most infusions were delivered noncontingently in the autoshaping phase. Rats acquired self-administration of α-PVP and 4MMC. Synthetic cathinone administration, and duration of exposure produced several effects on neurotransmitters. α-PVP primarily increased serotonin, 5-hydroxy-3-acetic acid (5-HIAA), norepinephrine, and glutamate in hypothalamus. In contrast, 4MMC decreased serotonin and 5-HIAA in several brain regions. Longer durations of exposure to both synthetic cathinones increased 5-HIAA, norepinephrine, and glutamate in multiple brain regions compared to the short exposure during autoshaping. Notably, both α-PVP and 4MMC produced minimal changes in dopamine levels, suggesting that the dopaminergic effects of these synthetic cathinones are transient. These alterations in neurotransmitter levels indicate that synthetic cathinone use may produce differential neurochemical changes during the transition from use to abuse.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-PVP; Female; Mephedrone; Neurotransmitter; Self-administration

Mesh:

Substances:

Year:  2019        PMID: 31493431      PMCID: PMC6783379          DOI: 10.1016/j.bbr.2019.112211

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  56 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  Plasticity of reward neurocircuitry and the 'dark side' of drug addiction.

Authors:  George F Koob; Michel Le Moal
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

3.  Micro-dissection of rat brain for RNA or protein extraction from specific brain region.

Authors:  Kin Chiu; Wui Man Lau; Ho Tak Lau; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  J Vis Exp       Date:  2007-08-30       Impact factor: 1.355

4.  Investigation of "bath salts" use patterns within an online sample of users in the United States.

Authors:  Patrick S Johnson; Matthew W Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 5.  Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).

Authors:  Richard A Glennon; Richard Young
Journal:  Brain Res Bull       Date:  2016-04-29       Impact factor: 4.077

6.  Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats.

Authors:  W J Lynch; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

7.  Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice.

Authors:  Michael D Berquist; M Melissa Peet; Lisa E Baker
Journal:  Behav Pharmacol       Date:  2015-02       Impact factor: 2.293

8.  Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.

Authors:  Krasnodara Cameron; Renata Kolanos; Rakesh Vekariya; Rakesh Verkariya; Louis De Felice; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2013-01-31       Impact factor: 4.530

9.  Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences.

Authors:  Heather E King; Alison Wakeford; William Taylor; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2015-07-26       Impact factor: 3.533

10.  Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Julie A Marusich; Kateland R Antonazzo; Jenny L Wiley; Bruce E Blough; John S Partilla; Michael H Baumann
Journal:  Neuropharmacology       Date:  2014-03-02       Impact factor: 5.250

View more
  4 in total

1.  MDPV self-administration in female rats: influence of reinforcement history.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2020-11-24       Impact factor: 4.530

2.  Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats.

Authors:  Julie A Marusich; Elaine A Gay; Scott L Watson; Bruce E Blough
Journal:  Eur J Pharmacol       Date:  2021-02-10       Impact factor: 4.432

3.  Insight into Glutamatergic Involvement in Rewarding Effects of Mephedrone in Rats: In Vivo and Ex Vivo Study.

Authors:  Olga Wronikowska; Maria Zykubek; Agnieszka Michalak; Anna Pankowska; Paulina Kozioł; Anna Boguszewska-Czubara; Łukasz Kurach; Artur Łazorczyk; Katarzyna Kochalska; Sylwia Talarek; Tymoteusz Słowik; Radosław Pietura; Joanna Kurzepa; Barbara Budzyńska
Journal:  Mol Neurobiol       Date:  2021-05-21       Impact factor: 5.590

4.  Vulnerability factors for mephedrone-induced conditioned place preference in rats-the impact of sex differences, social-conditioning and stress.

Authors:  Olga Wronikowska; Maria Zykubek; Łukasz Kurach; Agnieszka Michalak; Anna Boguszewska-Czubara; Barbara Budzyńska
Journal:  Psychopharmacology (Berl)       Date:  2021-07-15       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.